Karina Kulangara

4.6k total citations · 2 hit papers
32 papers, 2.6k citations indexed

About

Karina Kulangara is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Karina Kulangara has authored 32 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Karina Kulangara's work include Cancer Immunotherapy and Biomarkers (11 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and 3D Printing in Biomedical Research (8 papers). Karina Kulangara is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and 3D Printing in Biomedical Research (8 papers). Karina Kulangara collaborates with scholars based in United States, Switzerland and United Kingdom. Karina Kulangara's co-authors include Kam W. Leong, Eric M. Darling, Evelyn K. F. Yim, Farshid Guilak, Yong Yang, Kenneth Emancipator, Tania Rinaldi Barkat, Henry Markram, Malinka Jansson and Nancy R. Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Karina Kulangara

32 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells

2009 571 citations Evelyn K. F. Yim, Eric M. Darling et al. Biomaterials profile →
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer

2018 378 citations Karina Kulangara, Nancy R. Zhang et al. Archives of Pathology & Laboratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karina Kulangara United States	19	927	726	628	539	382	32	2.6k
Rosa S. Schneiderman Israel	24	1.4k 1.5×	387 0.5×	415 0.7×	762 1.4×	439 1.1×	77	3.8k
Adrian Ranga Belgium	23	1.6k 1.8×	477 0.7×	550 0.9×	1.1k 2.1×	607 1.6×	48	2.9k
Bo Ri Seo United States	24	1.5k 1.6×	564 0.8×	536 0.9×	580 1.1×	593 1.6×	30	3.5k
Nicolas Broguière Switzerland	23	1.4k 1.5×	688 0.9×	375 0.6×	821 1.5×	397 1.0×	34	2.5k
Damian C. Genetos United States	33	771 0.8×	442 0.6×	392 0.6×	1.4k 2.5×	486 1.3×	60	3.1k
Michael L. Smith United States	30	903 1.0×	307 0.4×	1.3k 2.0×	785 1.5×	309 0.8×	55	3.4k
Polina Goichberg Israel	24	941 1.0×	915 1.3×	1.7k 2.8×	1.4k 2.6×	565 1.5×	38	4.6k
Michele A. Wozniak United States	18	1.1k 1.2×	554 0.8×	1.8k 2.8×	1.1k 2.1×	244 0.6×	19	3.2k
John Leferovich United States	20	460 0.5×	603 0.8×	169 0.3×	1.3k 2.4×	282 0.7×	36	2.8k
Yoojin Shin South Korea	25	1.7k 1.8×	693 1.0×	277 0.4×	957 1.8×	209 0.5×	57	3.0k

Countries citing papers authored by Karina Kulangara

Since Specialization

Citations

This map shows the geographic impact of Karina Kulangara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karina Kulangara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karina Kulangara more than expected).

Fields of papers citing papers by Karina Kulangara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karina Kulangara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karina Kulangara. The network helps show where Karina Kulangara may publish in the future.

Co-authorship network of co-authors of Karina Kulangara

This figure shows the co-authorship network connecting the top 25 collaborators of Karina Kulangara. A scholar is included among the top collaborators of Karina Kulangara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karina Kulangara. Karina Kulangara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jansson, Malinka, et al.. (2023). PD-L1 IHC 22C3 pharmDx Demonstrates Precision and Reproducibility in Triple-negative Breast Cancer. 7(1). 1–9. 1 indexed citations

Polewski, Monika D., Malinka Jansson, Kenneth Emancipator, et al.. (2021). Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Head and Neck Squamous Cell Carcinoma. 5(1). 9–17. 2 indexed citations

Emancipator, Kenneth, et al.. (2021). Abstract PS4-15: Significance of PD-L1 expressing tumor cells in the combined positive score with triple negative breast cancer. Cancer Research. 81(4_Supplement). PS4–15. 1 indexed citations

Kulangara, Karina, Nancy R. Zhang, Ellie Corigliano, et al.. (2018). Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer. Archives of Pathology & Laboratory Medicine. 143(3). 330–337. 378 indexed citations breakdown →

Roach, Charlotte, Nancy R. Zhang, Ellie Corigliano, et al.. (2016). Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer. Applied immunohistochemistry & molecular morphology. 24(6). 392–397. 249 indexed citations

Kulangara, Karina, Jennifer Yang, Malathi Chellappan, Yong Yang, & Kam W. Leong. (2014). Nanotopography Alters Nuclear Protein Expression, Proliferation and Differentiation of Human Mesenchymal Stem/Stromal Cells. PLoS ONE. 9(12). e114698–e114698. 27 indexed citations

Kulangara, Karina, Andrew F. Adler, Hong Wang, et al.. (2014). The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons. Biomaterials. 35(20). 5327–5336. 80 indexed citations

Kulangara, Karina, Yong Yang, Jennifer Yang, & Kam W. Leong. (2012). Nanotopography as modulator of human mesenchymal stem cell function. Biomaterials. 33(20). 4998–5003. 122 indexed citations

Adler, Andrew F., Christopher L. Grigsby, Karina Kulangara, et al.. (2012). Nonviral Direct Conversion of Primary Mouse Embryonic Fibroblasts to Neuronal Cells. Molecular Therapy — Nucleic Acids. 1. e32–e32. 53 indexed citations

10.

Kulangara, Karina, et al.. (2011). Dynamic Topographical Control of Mesenchymal Stem Cells by Culture on Responsive Poly(ϵ‐caprolactone) Surfaces. Advanced Materials. 23(29). 3278–3283. 115 indexed citations

11.

Chalut, Kevin J., Karina Kulangara, Adam Wax, & Kam W. Leong. (2011). Stem cell differentiation indicated by noninvasive photonic characterization and fractal analysis of subcellular architecture. Integrative Biology. 3(8). 863–863. 8 indexed citations

12.

Yang, Yong, et al.. (2011). Engineering of a microfluidic cell culture platform embedded with nanoscale features. Lab on a Chip. 11(9). 1638–1638. 56 indexed citations

13.

Chalut, Kevin J., Karina Kulangara, Michael G. Giacomelli, Adam Wax, & Kam W. Leong. (2010). Deformation of stem cell nuclei by nanotopographical cues. Soft Matter. 6(8). 1675–1675. 64 indexed citations

14.

Yim, Evelyn K. F., Eric M. Darling, Karina Kulangara, Farshid Guilak, & Kam W. Leong. (2009). Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials. 31(6). 1299–1306. 571 indexed citations breakdown →

15.

Rey, Guillaume, et al.. (2008). Subunit-specific surface mobility of differentially labeled AMPA receptor subunits. European Journal of Cell Biology. 87(10). 763–778. 11 indexed citations

16.

Yersin, Alexandre, Harald Hirling, Sandor Kasas, et al.. (2007). Elastic Properties of the Cell Surface and Trafficking of Single AMPA Receptors in Living Hippocampal Neurons. Biophysical Journal. 92(12). 4482–4489. 15 indexed citations

17.

Steiner, Pascal, Stefano Alberi, Karina Kulangara, et al.. (2005). Interactions between NEEP21, GRIP1 and GluR2 regulate sorting and recycling of the glutamate receptor subunit GluR2. The EMBO Journal. 24(16). 2873–2884. 92 indexed citations

18.

Kulangara, Karina, et al.. (2005). Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling. Cellular and Molecular Life Sciences. 62(2). 179–187. 38 indexed citations

19.

Steiner, Pascal, Karina Kulangara, J.‐C. Floyd Sarria, et al.. (2004). Reticulon 1‐C/neuroendocrine‐specific protein‐C interacts with SNARE proteins. Journal of Neurochemistry. 89(3). 569–580. 74 indexed citations

20.

Kulangara, Karina, et al.. (2003). Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells.. PubMed. 63(2). 534–40. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact